260 related articles for article (PubMed ID: 32200821)
1. Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids.
Thorne JE; Woreta FA; Dunn JP; Jabs DA
Ophthalmology; 2020 Apr; 127(4S):S21-S26. PubMed ID: 32200821
[TBL] [Abstract][Full Text] [Related]
2. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids.
Thorne JE; Woreta FA; Dunn JP; Jabs DA
Ophthalmology; 2010 Jul; 117(7):1436-41. PubMed ID: 20363502
[TBL] [Abstract][Full Text] [Related]
3. Risk of Hypotony in Juvenile Idiopathic Arthritis-Associated Uveitis.
Moradi A; Stroh IG; Reddy AK; Hornbeak DM; Leung TG; Burkholder BM; Thorne JE
Am J Ophthalmol; 2016 Sep; 169():113-124. PubMed ID: 27345732
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study.
Gregory AC; Kempen JH; Daniel E; Kaçmaz RO; Foster CS; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE;
Ophthalmology; 2013 Jan; 120(1):186-92. PubMed ID: 23062650
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis.
Lam LA; Lowder CY; Baerveldt G; Smith SD; Traboulsi EI
Am J Ophthalmol; 2003 Jun; 135(6):772-8. PubMed ID: 12788115
[TBL] [Abstract][Full Text] [Related]
6. Nuclear cataract as an early predictive factor for recalcitrant juvenile idiopathic arthritis-associated uveitis.
Suelves AM; Lamba N; Meese HK; Foster CS; González-Martín JM; Díaz-Llopis M; Christen WG
J AAPOS; 2016 Jun; 20(3):232-238.e1. PubMed ID: 27164426
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for the Development of Cataract in Children with Uveitis.
Blum-Hareuveni T; Seguin-Greenstein S; Kramer M; Hareuveni G; Sharon Y; Friling R; Sharief L; Lightman S; Tomkins-Netzer O
Am J Ophthalmol; 2017 May; 177():139-143. PubMed ID: 28257832
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis.
Woreta F; Thorne JE; Jabs DA; Kedhar SR; Dunn JP
Am J Ophthalmol; 2007 Apr; 143(4):647-55. PubMed ID: 17224116
[TBL] [Abstract][Full Text] [Related]
9. Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases.
Yamazaki S; Shimbo A; Akutsu Y; Takase H; Morio T; Mori M
Pediatr Rheumatol Online J; 2020 Mar; 18(1):26. PubMed ID: 32293465
[TBL] [Abstract][Full Text] [Related]
10. Intraocular lens implantation in patients with juvenile idiopathic arthritis-associated uveitis.
Kotaniemi K; Penttila H
Ophthalmic Res; 2006; 38(6):318-23. PubMed ID: 17047403
[TBL] [Abstract][Full Text] [Related]
11. Juvenile arthritis-associated uveitis: visual outcomes and prognosis.
Chen CS; Roberton D; Hammerton ME
Can J Ophthalmol; 2004 Oct; 39(6):614-20. PubMed ID: 15559647
[TBL] [Abstract][Full Text] [Related]
12. Juvenile idiopathic arthritis-associated uveitis at an Italian tertiary referral center: clinical features and complications.
Paroli MP; Abbouda A; Restivo L; Sapia A; Abicca I; Pivetti Pezzi P
Ocul Immunol Inflamm; 2015 Feb; 23(1):74-81. PubMed ID: 24329729
[TBL] [Abstract][Full Text] [Related]
13. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and potential complications of difluprednate use for pediatric uveitis.
Slabaugh MA; Herlihy E; Ongchin S; van Gelder RN
Am J Ophthalmol; 2012 May; 153(5):932-8. PubMed ID: 22265149
[TBL] [Abstract][Full Text] [Related]
15. Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study.
Rypdal V; Glerup M; Songstad NT; Bertelsen G; Christoffersen T; Arnstad ED; Aalto K; Berntson L; Fasth A; Herlin T; Ekelund M; Peltoniemi S; Toftedal P; Nielsen S; Leinonen S; Bangsgaard R; Nielsen R; Rygg M; Nordal E;
Ophthalmology; 2021 Apr; 128(4):598-608. PubMed ID: 32866542
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.
Pichi F; Nucci P; Baynes K; Lowder CY; Srivastava SK
Int Ophthalmol; 2017 Feb; 37(1):221-228. PubMed ID: 27221263
[TBL] [Abstract][Full Text] [Related]
17. Risk of Cataract in Intermediate Uveitis.
Minkus CL; Pistilli M; Dreger KA; Fitzgerald TD; Payal AR; Begum H; Kaçmaz RO; Jabs DA; Nussenblatt RB; Rosenbaum JT; Levy-Clarke GA; Sen HN; Suhler EB; Thorne JE; Bhatt NP; Foster CS; Buchanich JM; Kempen JH;
Am J Ophthalmol; 2021 Sep; 229():200-209. PubMed ID: 33713679
[TBL] [Abstract][Full Text] [Related]
18. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss.
Thorne JE; Woreta F; Kedhar SR; Dunn JP; Jabs DA
Am J Ophthalmol; 2007 May; 143(5):840-846. PubMed ID: 17362866
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features of glucocorticoid eye drops induced ocular hypertension in pediatric and adult uveitic eyes].
Pei MH; Zhao C; Gao F; Zhang MF
Zhonghua Yan Ke Za Zhi; 2018 Nov; 54(11):839-842. PubMed ID: 30440155
[No Abstract] [Full Text] [Related]
20. Fluocinolone acetonide intravitreal implant (Retisert
Leinonen S; Immonen I; Kotaniemi K
Acta Ophthalmol; 2018 Sep; 96(6):648-651. PubMed ID: 29655222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
